On this week’s episode of China of Tomorrow, Liqian Ren is joined by Co-founder and Chief Executive Officer Peter Luo, PhD at Adagene, a biotech company that is applying its AI powered technology platform to develop new antibody treatments for cancer. During the episode, Liqian and Dr. Luo cover the latest developments in the pharmaceutical industry affecting productivity rates in research and development, and their established practices when conducting business globally specifically, in China and more.